[CHRS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -52.68%
YoY- -40.62%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 87,643 83,034 110,419 113,551 135,674 116,180 123,856 -20.60%
PBT -29,900 -172,947 10,760 28,116 60,325 36,505 41,271 -
Tax 5,758 5,709 1,052 183 1,294 933 2,044 99.58%
NP -29,900 -172,947 9,708 27,933 59,031 35,572 39,227 -
Tax Rate - - -9.78% -0.65% -2.15% -2.56% -4.95% -
Total Cost 117,543 255,981 100,711 85,618 76,643 80,608 84,629 24.51%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -34.12 -208.28 8.79 24.60 43.51 30.62 31.67 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.40 -2.37 0.13 0.39 0.83 0.50 0.56 -
EPS Diluted -0.40 -2.37 0.12 0.33 0.70 0.48 0.53 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.